Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic kidney disease […]
Halia Therapeutics announced the appointment of Dr. Margit M. Janát-Amsbury, MD, Ph.D. as the company’s Chief Medical Officer […]
ARUP Laboratories and the University of Utah’s Division of Medical Laboratory Sciences have secured $3 million in federal funding. […]
Inherent Biosciences has teamed up with Posterity Health, the only virtual Male Fertility Center of Excellence, to address male fertility […]
Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease […]
New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain […]
Wykoff to build upon more than two decades of public and private sector healthcare leadership to head up delivering Nomi Health’s core business offerings […]
Congress is expected to vote this week on a massive omnibus government funding bill that would run through the end of the 2023 fiscal year. The legislative text was released on Tuesday. The $1.7 trillion, 4,155-page bill includes a number of significant healthcare provisions. Of particular interest to the life sciences industry are provisions included […]
IONIQ is “Clinical Diagnostics Solution of the Year 2022” […]
For IONIQ Sciences, 2022 was another big year. As we respond to the FDA’s substantive review of our De Novo application for the ‘breakthrough‘ IONIQ ProLung Test, powerful macroeconomic factors are highlighting the importance of early cancer detection. Despite uncertain conditions in the financial market, we have a compelling message for potential institutional and strategic investors at […]
The 2022 TEConomy/BIO report, The US Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward, examines the bioscience industry’s impact on the national economy and provides state specific data, with Utah and its major metropolitan areas ranking high in specialized employment concentration in three major subsectors – medical device manufacturing, pharmaceuticals, research, testing and medical laboratories […]
The annual Life Sciences Day on the Hill provides our industry with the opportunity to get face time with legislators and other government officials during the 2023 legislative session. Slated for Friday, January 27, 2023 from 11:00 AM to 2:00 PM, the event permits BioUtah members to demonstrate their important breakthroughs, devices and innovations. It […]